Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$533M |
| 2 |
Apple
AAPL
|
+$347M |
| 3 |
Micron Technology
MU
|
+$272M |
| 4 |
Eli Lilly
LLY
|
+$232M |
| 5 |
Super Micro Computer
SMCI
|
+$185M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$472M |
| 2 |
NVIDIA
NVDA
|
+$413M |
| 3 |
Tesla
TSLA
|
+$403M |
| 4 |
Coinbase
COIN
|
+$236M |
| 5 |
Johnson & Johnson
JNJ
|
+$224M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.66% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Industrials | 9.63% |
| 5 | Financials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRTA
2526
Strata Critical Medical Inc
SRTA
$495M
| $875K | ﹤0.01% |
297,700
+6,400
| +2% | +$20.4K |
|
2527
Global X SuperDividend ETF
SDIV
$1.2B
| $875K | ﹤0.01% |
37,171
-25,829
| -41% | -$577K |
|
2528
St. Joe Company
JOE
$3.84B
| $875K | ﹤0.01% |
+15,002
| New | +$879K |
|
2529
Meridian
MRBK
$235M
| $875K | ﹤0.01% |
69,200
+34,600
| +100% | +$394K |
|
2530
Shattuck Labs
STTK
$684M
| $875K | ﹤0.01% |
250,600
-141,410
| -36% | -$527K |
|
|
TTSH
2531
DELISTED
Tile Shop Holdings
TTSH
| $870K | ﹤0.01% |
132,025
+22,025
| +20% | +$143K |
|
|
AC
2532
DELISTED
Associated Capital Group
AC
| $868K | ﹤0.01% |
24,500
-200
| -0.8% | -$6.56K |
|
2533
Adaptive Biotechnologies
ADPT
$3.75B
| $867K | ﹤0.01% |
169,400
+17,600
| +12% | +$76.7K |
|
|
GLDG
2534
GoldMining Inc
GLDG
$207M
| $867K | ﹤0.01% |
922,200
+631,000
| +217% | +$569K |
|
2535
Lowe's Companies
LOW
$122B
| $867K | ﹤0.01% |
+3,200
| New | +$775K |
|
2536
Alta Equipment Group
ALTG
$240M
| $866K | ﹤0.01% |
128,500
+41,200
| +47% | +$317K |
|
2537
SmartRent
SMRT
$264M
| $866K | ﹤0.01% |
500,600
+302,900
| +153% | +$575K |
|
|
INZY
2538
DELISTED
Inozyme Pharma
INZY
| $862K | ﹤0.01% |
164,800
-23,039
| -12% | -$120K |
|
2539
Star Holdings Shares of Beneficial Interest
STHO
$115M
| $859K | ﹤0.01% |
62,099
+31,899
| +106% | +$414K |
|
2540
Wave Life Sciences
WVE
$1.19B
| $857K | ﹤0.01% |
+104,520
| New | +$625K |
|
2541
AGF US Market Neutral Anti-Beta Fund
BTAL
$307M
| $853K | ﹤0.01% |
+43,525
| New | +$866K |
|
|
OKUR
2542
OnKure Therapeutics
OKUR
$168M
| $853K | ﹤0.01% |
50,153
+5,933
| +13% | +$87.8K |
|
|
GOGL
2543
DELISTED
Golden Ocean Group
GOGL
| $852K | ﹤0.01% |
+63,700
| New | +$792K |
|
|
SNT
2544
Senstar Technologies
SNT
$43.4M
| $850K | ﹤0.01% |
534,869
-7,000
| -1% | -$11.6K |
|
2545
Community Health Systems
CYH
$416M
| $850K | ﹤0.01% |
140,093
-397,000
| -74% | -$1.95M |
|
2546
InnovAge Holding
INNV
$1.49B
| $849K | ﹤0.01% |
141,500
+5,100
| +4% | +$30.3K |
|
2547
Abeona Therapeutics
ABEO
$393M
| $849K | ﹤0.01% |
134,278
-369,015
| -73% | -$1.93M |
|
2548
iShares US Financials ETF
IYF
$4.61B
| $842K | ﹤0.01% |
8,100
+5,600
| +224% | +$562K |
|
2549
iShares Russell Mid-Cap ETF
IWR
$56.7B
| $837K | ﹤0.01% |
+9,500
| New | +$800K |
|
2550
Century Therapeutics
IPSC
$343M
| $835K | ﹤0.01% |
488,200
+322,700
| +195% | +$632K |
|
Similar funds
Renaissance Technologies's Q3 2024 Portfolio in Review
As of Q3 2024, Renaissance Technologies held 4,024 positions worth $66.5B, up 13% from $59B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies deployed $3.2B of net new capital in Q3 2024, opening 578 new positions and adding to 1,558 existing holdings. Its largest new stake was Micron Technology: 2,604,914 shares worth $270M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $413M trimmed.
- Renaissance Technologies's largest Q3 2024 buy was Micron Technology: 2,604,914 shares worth $270M.
- Renaissance Technologies added most to Microsoft in Q3 2024, an estimated $533M increase.
- Renaissance Technologies's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $413M.
- Renaissance Technologies fully exited Broadcom in Q3 2024, selling an estimated $472M.
- Renaissance Technologies's ten largest holdings make up 11% of its $66.5B portfolio in Q3 2024.
- Renaissance Technologies opened 578 new positions and closed 539 in Q3 2024.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $66.5B.
Based on Renaissance Technologies's 13F filing for Q3 2024, filed 13 Nov 2024.